ALL vs EBS
The Allstate Corporation (ALL) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ALL and EBS stock pages for the full models.
Not investment advice.